Asia Pacific & Australia

Article Suggests Thailand Being Flooded By US Cannabis Imports

Published

2 years ago

April 7, 2023

admin

Newsweed reports

Kajkanit Sakdisubha, CEO and founder of Taratera, which operates cannabis farms and shops, told Reuters that illegal imports began when the post-decriminalization sales boom led to the depletion of the domestic supply.

“That’s when the imported flowers started arriving,” says Kajkanit.

According to three industry members, at least half of the cannabis sold in Thailand is smuggled in, although they have no estimate of the quantity or value of the imports.

Pro-cannabis activist and retailer Chokwan “Kitty” Chopaka said the United States was the main source of the cannabis that has flooded Thailand, especially in its tourist hubs.

“Much of the cannabis coming from the United States is destined for dispensaries in Bangkok, Phuket or Pattaya,” she said.

Local farmers impacted

Pornchai Padmindra of the Thai Industrial Hemp Trade Association, which has about 300 members, said that as profit margins shrink, many growers are considering exiting the industry.

“People are struggling,” he said. “Things are getting tough. »

The large quantities of cannabis smuggled from abroad have indeed lowered wholesale prices and ultimately harmed growers.

The Thai Chamber of Commerce has estimated the sector could be worth $1.2 billion by 2025, but cultivator Srapathum Natthapong, 37, who has invested much of his savings to get into the industry, said said he had seen his income decline.

“At first, I could sell a kilo for between 350,000 and 400,000 baht (10,000 to 11,000 euros),” Srapathum Natthapong, a cannabis grower who operates three indoor farms, told Reuters.

In April, the date of the next harvest, Srapathum expects the price to have fallen to 200,000 baht (5,500 euros) per kilo.

“Smuggling harms us,” he said.

1.1 million people in Thailand have registered with the government to grow cannabis. It is not known if all do this or how many people grow cannabis without registering.

https://www.newsweed.fr/cannabis-vendu-thailande-etats-unis/

Source link

Asia Pacific & Australia

Australia’s Zenith Cannabis Clinic Throws Up More Question Marks.. It Appears They Are Providing Consults But Have No TGA Approval To Prescribe

Published

2 months ago

September 19, 2024

admin

Hi I noticed you had a post about Zenith clinics I recently had a run in with them as I was seeking medication.

They are a scam they take your money which was $29 for the initial consult which they say they will return it’s just a pending holding fee for the consult.

A “so called doctor gives you a call on zoom they prescribe you”.

After two weeks nothing happened I called several times and got the same person with a south African accent they keep on telling me they are waiting for TGA approval this goes on and on they say it sometimes takes a long time.

I was fed up so I called ******* scripts got a free appointment the next day she prescribed me and the TGA approval only took 48hrs and I have the product now already.

I am yet to hear back from Zenith clinic. It’s not the money as it was only $29 but it’s the deception they must be doing this to a lot of people who really need medicine. I wanted to send this as people need to be warned so they are to right decision.

Source link

Asia Pacific & Australia

SOMAI Boss Says Australian Medical Cannabis Programme Is World Beater

Published

8 months ago

March 27, 2024

admin

Respectfully we’d disagree – this is what he told Cannabiz Australia

The Australian medical cannabis industry may have its challenges, but its focus on affordable access and patient care make it a role model for the rest of the world, says SOMAÍ Pharmaceuticals chairman and CEO Michael Sassano.

The Australian market has become one of only three significant global medical cannabis markets in the world.

Although all eyes are on the US potentially rescheduling the substance after Germany removed the narcotics label from cannabis medicines, the Australian market continues to expand faster than most because of the focus on what is best for patients and their experience.

Australia leads in cannabis choice and pricing

Doctor and patient relationships and freedom of choice for both parties help to form the foundation of a solid medical cannabis market. When the focus is on limiting access instead, problems arise.

Michael Sassano

For example, Israel only permits flower sales and limits other products, such as extracts. Germany’s market focuses on the magistral preparation of extracts with a minimal framework for different form factors like gel capsules or faster-acting excipients.

As another example, seniors in the US are a growing market that may consume cannabis in low dosages for arthritis. Their preferred administrative and dosage choice is a mild 1:50 gel capsule or edible format. With flower-only restrictions, they would have to roll a joint or use a smoking pipe instead. Massive market segments are being excluded from access because they simply don’t want to smoke.

Australia is far beyond other larger markets regarding choice with patients having close to 1,000 medical cannabis product choices. Giving options to doctors and patients is precisely what the cannabis-as-medicine movement has always been about, not a one-size-fits-all therapy program.

The country has also embraced lower consumer pricing, making daily medicine more affordable and accessible. All favourable consumer markets give patients ample choice and affordable pricing, providing access to everyday necessities.

Read the full article